1 / 36

Common Posterior Pole Disorders

Common Posterior Pole Disorders. Kelli Shaon, O.D. Macular Degeneration. Age Related Macular Degeneration. Leading cause of legal blindness in those >65 years of age More common in Caucasians, much less common in African-American

auryon
Télécharger la présentation

Common Posterior Pole Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Common Posterior Pole Disorders Kelli Shaon, O.D.

  2. Macular Degeneration

  3. Age Related Macular Degeneration • Leading cause of legal blindness in those >65 years of age • More common in Caucasians, much less common in African-American • More common in Cigarette smokers, those w/ significant light (sun) exposure, and family history (sibling or parental), & associated systemic disorders (HTN, Hyperlipidemia, and DM) • Presents in 2 forms: • Dry (non-exudative) – 90% • Wet (exudative) – 10%

  4. Dry (Non-exudative) ARMD • Signs: • Hard drusen* – • Round, discrete, punctate yellowish deposits • Not diagnostic of ARMD but need to monitor • Soft drusen - • Larger, indistinict, paler yellow deposits (can become confluent) – more likely to ↓ VA • RPE clumping (mottling, changes) • Breakdown of RPE • Geographic atrophy • Gradual, progressive loss of RPE and choriocapillaris (visible choroidal vessels on examination)

  5. Dry (Non-exudative) ARMD • Hard drusen • Fine, discrete yellow • Soft drusen • Confluent, larger, pale

  6. Dry (Non-exudative) ARMD • RPE mottling: • RPE distruption • Geographic atrophy: • RPE & choriocapillaris destruction (visible choroidal vessels)

  7. Dry (Non-exudative) ARMD • Clinical Pearls: • 90% of all ARMD*** • Bilateral, but can be asymmetrical • Vision can vary from 20/20 (with Drusen &/or RPE changes only to <20/200 from geographic atrophy)

  8. Dry (Non-exudative) ARMD • Management: • Should be monitored for progression to exudative (wet) form • Follow-up time will vary based on severity • An ↑ in the # of Soft, confluent drusen ↑ the risk of progression to wet – f/u should be sooner • Home Amsler grid are most common way for pt. To monitor for changes (metamorphopsia) • Stop smoking • Vitamin supplement (AREDS formula) • Vitamins A (beta-carotene), C, E, zinc, & copper • NO Beta-carotene (Vit. A) for smokers (or those who have smoked in past 10-15 years) – Ocuvite w/ Lutein is altern.

  9. Wet (Exudative) ARMD • Signs: • Grayish-green discoloration in macular (CNVM) • New vessel growth that develops & grows through a disruption in Bruch’s membrane • Sub-retinal hemorrhage • Deeper, darker red colored hemorrhage often associated w/ exudates • RPE detachment or sensory retinal detachment • Detachment of RPE or sensory retinal in macula • Disciform scar • Fibrovascular scarring secondary to old leakage from a ruptured/leakage in a CNVM

  10. Macular Photocoagulation Study (MPS): • Eyes with soft drusen – 30% risk of CNVM • Eyes w/o large, soft drusen & w/o pigment abnormalities – had 10% risk of CNVM • Patients with CNVM in 1 eye have a 58-73% chance of developing CNVM in fellow eye in 5 years if… • 2 or more large drusen & focal hyperpigmentation of the macula

  11. Choroidal Neovascular Membrane • IVFA: • Top - Classic CNVM • Bottom - Occult CNVM

  12. Wet (Exudative) ARMD • Top – Pigment epithelium detachment (PED) • Bottom – Disciform scar

  13. Wet (Exudative) ARMD • Management/Treatment: • Laser photocoagulation • MPS study demonstrated that severe vision loss can be reduced in patients w/ extrafoveal wet ARMD • MPS showed 10-15% of CNVM are treatable w/ Argon photocoagulation • Photodynamic therapy (PDT) – Vertiporfen (Visudyne) • Light-activated drug (approved for ARMD, Histoplasmosis, & Pathological myopia) • Sub-macular surgery • Removal of CNVM • Macular Translocation • Movement of macula to functioning part of retina • New treatments – • Macugen - VEGF-I injection  q 6 weeks – FDA approved • Lucentis - VEGF-I injection  q 4weeks • Retanne - deriv. of corticosteroid, juxtascleral q 6 monhts

  14. Additional Causes of CNVM

  15. Additional Causes of CNVM • Choroidal rupture • Unilateral • Etiology: Blunt Force Trauma • Sign: Circumferential breaks in Bruch’s

  16. Additional Causes of CNVM • Myopic Degeneration • Bilateral Involvement • Etiology: Pathological (High) Myopia – • Defined as at least 6 diopters of axial myopia that has created thinning of the RPE and choroid • Signs: Lacquer cracks, Fuch’s spots, staphylomas, &/or choroidal atrophy

  17. Additional Causes of CNVM • Angioid Streaks • Bilateral involvment • Breaks in bruch’s membrane that are thickened & calcified – peau de’ orange appearance • Most associated systemic dz: • Pseudoxanthoma elasticum (PXE)** • Paget’s disease • Sickle cell disease

  18. Additional Causes of CNVM • Histoplasmosis (POHS) • Bilateral • Etiology: Fungus commonly found in soil (Histoplasma capsulatum) • Often from bird & bat feces • Concentrated along Ohio-Mississippi river valley • Fundus findings: Classic Triad • Punched-out lesions (histo spots) • Peripapillary atrophy (PPA) • CNVM

  19. Common Macular Disorders

  20. Central Serous Chorioretinopathy • Unilateral, serous detachment of macula • Most commonly affected: • Type-A personalities • Male>>Female (10:1) • Usually between 20-60 yo • Common signs: • Metamorphopsia • “Smokestack” on FA - classic • Management: • Monitor • Lifestyle changes • NSAIDs (??) • Laser photocoagulation (if fail to improve)

  21. Cystoid Macular Edema (CME) • Fluid accumulation in the OPL & INL of retina (centered in fovea) • Associations: • Post CE (Irvin-Gass Syndrome) • Medications: • Niacin, Xalatan (Prostoglandins), Epinephrine • Signs: • Reduced vision • Metamorphopsia • Treatments: • Topical NSAID (Acular QID) • Non-generic Pred Forte 1% QID • Possible Grid Photocoagulation

  22. Epiretinal Membrane (ERM) • AKA: cellophane maculopathy; Macular pucker • Associated w/ a break in ILM & cellular proliferation on the surface (creates surface wrinkling) • Early stages = glistening area of retina • Later stages ↑ contraction & density of ERM ( ↑ wrinkling of retina & tortuosity of vessels • Treatment: • Early stages: Monitor w/ Amsler • Late stages: Membrane peel

  23. Macular Hole • Etiology:??, thought to be tugging at macular due to PVD • Stages: • Stage 1: Foveal detachment (20/25-20/70) • A: Yellow spot in fovea • B: Yellow ring in Fovea • Stage 2: Early Hole formation (20/25-20/100) • Stage 3: Fully developed hole w/ vitreoretinal separation but NO PVD • 97% will have (+) Watzke- Allen • Stage 4: Full-thickness macular hole w/ PVD (only 10-20%

  24. Macular Hole • Treatment: • Stage 1: Get Retina Consult –However, 50% of stage will spontaneously regress • Stage 2 & 3: Also get Retina consult, vitrectomy may help • Stage 4 – Monitor ? • If macular hole in 1 eye & PVD in other eye, little risk of fellow getting macular hole • If macular hole in 1 eye & No PVD in other eye 28-44% chance of fellow eye developing macular hole • Before you get a consult - Can your pt handle surgery? • face down position for 7 days

  25. Macula Pseudo-hole • Looks similar to macular hole, • Differences: • Vision should be good (most 20/20) • (-) Watzke-Allen • It is actually a ERM that develops a hole in the membrane over the macula

  26. Retina/Vitreous Inflammation

  27. Toxoplasmosis • Infection by the protozoan Toxoplasma gondii • found in cat feces (intestinal phase), cells of the host & in tissue of raw, under cooked meat (extra-intestinal phase) • Most common posterior uveitis in the US • Signs: • Yellow-white retinal lesions (satellite lesions), often associated with old chorioretinal scars • Focal vitreous inflammation is also possible • Treatment/Management: • Order serum anti-Toxoplasma antibody titer – should be (+) • Disease is usually self-limited in immuno-competent patient (Treat the AC uveitis if present, then & monitor) • Systemic Tx is used if immuno-compromised patient or if macula is threatened – Drugs are toxic, work w/ PCP to Tx

  28. Toxoplasmosis • Findings: • (+) Group of 3 CR scars • (+) Non-pigmented raised lesion, possible Satellite lesion • (+) Vitreous Strands

  29. Toxocariasis • Infection by nematode larvae • Most commonly of Toxocara canis or Toxocara cati • Signs: • Fibrous band often radiating from white retinal mass • Leukocoria can be present • Treatment: • Retina consult for photocoagulation or transvitreal removal of worm • Possible oral antihelmonthic drugs (controversial)

  30. Sarcoidosis • Background: • Systemic granulomas disease • Most common involvement includes the eyes, hilar adenopathy w/ associated breathing difficulties, enlargement of parotid gland, facial nerve palsy, tender skin nodules, & arthritis • Much more common in African-Americans than Caucasians • Female > Male • An average of 40% of indiv. w/ sarcoidosis will have eye signs

  31. Sarcoidosis • Ocular signs: • Granulomatous Anterior Uveitis** • LARGE Mutton-fat KPs • Koeppe & Busacca nodules or the iris • Possible residual or current PAS (peripheral anterior synchiae) • Sheathing of peripheral retinal veins – “candle-wax drippings”** • String of pearls vitreous opacities • Lacrimal gland infiltation w/ KCS following (severe dry eyes)* • Resultant Cataracts • Resultant Glaucoma (inflammation related)

  32. Sarcoidosis • Diagnosis: • Chest X-ray – (+) bilateral hilar adenopathy • Serum ACE – elevated 60-90% of patients • May want to order PPD – to r/o out TB • Management: • Anterior uveitis: Cycloplegic + Pred Forte 1% • Posterior uveitis: systemic &/or periocular steroids (Obtain retina or ophthalmology consult) – Topical steroids will NOT be effective enough for posterior involvement

  33. Sarcoidosis

  34. AIDS associated Retinopathy • Common findings: • CWS*** • DDx: Interferon Retinopathy – from Hepatitis C treatment • Flame hemes • Roth spots • DDx: leukemia, Bacterial endocarditis, DM

  35. AIDS associated Retinopathy • CMV Retinitis: “Cheese & Sauce” • Infiltrative necrosis • White intraretinal lesions • Intraretinal hemmorhages • Exudative retinal detachments

  36. The End

More Related